ALCIDION GROUP LIMITED — Capital/Financing Update 2021

Dec 6, 2021

==> picture [167 x 44] intentionally omitted <==

7 December 2021

Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000

Pro-rata Accelerated Non-Renounceable Entitlement Offer Notice under Section 708AA(2)(f) Corporations Act 2001 (Cth)

Melbourne, Victoria - This notice is given by Alcidion Group Limited (ASX:ALC) ( Alcidion ) under section 708AA(2)(f) of the Corporations Act 2001 (Cth) ( Corporations Act ) as modified by ASIC Corporations (Non-Traditional Rights Issues) Instrument 2016/84 and ASIC Corporations (Disregarding Technical Relief) Instrument 2016/73 ( Legislative Instruments ).

Alcidion has announced a pro-rata accelerated non-renounceable entitlement offer ( Entitlement Offer ) of 1 fully paid ordinary share in Alcidion ( Shares ) for every 10.5 Shares held as at 7.00pm (Melbourne time) on Thursday, 9 December 2021 by shareholders with a registered address in Australia, New Zealand and certain other jurisdictions in which Alcidion decides to extend the Entitlement Offer.

Further details regarding the Entitlement Offer are set out in the ASX Announcement and investor presentation accompanying this notice. A Retail Offer Booklet for the Entitlement Offer is expected to be dispatched to eligible retail investors on Tuesday, 14 December 2021.

For the purposes of Section 708AA(7) of the Corporations Act, Alcidion hereby confirms that:

• a) the Shares to be issued under the Entitlement Offer ( New Shares ) will be offered without disclosure under Part 6D.2 of the Corporations Act;

• b) this notice is being given under Section 708AA(2)(f) of the Corporations Act;

• c) as at the date of this notice Alcidion, has complied with:

  • (i) the provisions of Chapter 2M of the Corporations Act as they apply to Alcidion; and

  • (ii) section 674 and 674A of the Corporations Act;

• d) as at the date of this notice, there is no excluded information of the type referred to in sections 708AA(8) and 708AA(9) of the Corporations Act that is required to be set out in this notice under section 708AA(7)(d) of the Corporations Act; and

• e) the potential effect that the issue of the New Shares will have on the control of Alcidion, and the consequences of that effect, will depend on a number of factors, including investor demand and existing shareholders. Nevertheless, given:

  • (i) the size and pricing of the Entitlement Offer;

  • (ii) that the Entitlement Offer is structured as a pro-rata issue and is fully underwritten; and

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com [8758658: 31375853_1]

==> picture [167 x 44] intentionally omitted <==

• (iii) the current level of holdings of substantial holders in Alcidion (based on substantial holding notices that have been given to Alcidion and lodged with ASX on or prior to the date of this notice),

the issue of the New Shares under the Entitlement Offer is not expected to have a material effect or consequence on the control of Alcidion.

ENDS

For and on behalf of the Board:

For further information, please contact:

Melanie Leydin Hannah Howlett Company Secretary WE Communications Ph: +61 3 9692 7222 Ph: +61 4 5064 8064 hhowlett@we-worldwide.com

About Alcidion

Alcidion Limited (ASX:ALC) has a simple purpose: to transform healthcare with smart, intuitive technology solutions that meet the needs of hospital and allied healthcare, worldwide. It offers a complementary set of software products and services that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. In 2017 Alcidion acquired Oncall System and its Smartpage clinical communication system. In 2018 it acquired the Patientrack bedside patient monitoring software and MKM Health, an IT solutions and services provider. These offerings now operate under the Alcidion brand. With over 25 years of combined healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

© Alcidion Group Limited 2019. Alcidion, MKM Health, Miya, Patientrack and Smartpage are registered trademarks. All other brands and product names and trademarks are the registered property of their respective companies.

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com [8758658: 31375853_1]